Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent

Bioconjugate Chemistry

Volumn 12, Issue 3, 2001, Pages 354-363

  Gali, Hariprasad ^a   Hoffman, Timothy J ^a,c   Sieckman, Gary L ^c   Owen, Nellie K ^a   Katti, Kattesh V ^a,b   Volkert, Wynn A ^a,b,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHELATION; CHLORINE COMPOUNDS; COORDINATION REACTIONS; DIAGNOSIS; DISEASE CONTROL; ESTERS; METHANOL; PHOSPHORUS COMPOUNDS; TIN COMPOUNDS; TRANSITION METALS;

BIFUNCTIONAL CHELATING AGENT; BIS(HYDROXYMETHYL); BISPHOSPHINE; BOMBESIN ANALOGUES; CHELATING AGENT; EFFECTIVE APPROACHES; ELECTRON-DONATING GROUP; LABELINGS; PHOSPHONIUM SALTS; RADIOLABELLING;

PEPTIDES;

ANIMALIA;

EID: 0035012702     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc000077c     Document Type: Article

References (54)

1. 99mTc-Labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev. 99, 2235-2268.
2. Volkert, W. A., and Hoffman, T. J. (1999) Therapeutic radiopharmaceuticals. Chem. Rev. 99, 2269-2292.
3. 99mTc-Labeled small peptide-based radiopharmaceuticals: An overview. Nucl. Med. Commun. 20, 1093-1112.
4. 3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur. J. Nucl. Med. 24, 368-371.
5. Hoffman, T. J., Smith, C. J., Simpson, S. D., Sieckman, G. L., Higginbotham, C., Jimenez, H., Eshima, D., Thornback, J. R., and Volkert, W. A. (2000) Targeting Gastrin Releasing Peptide Receptor (GRP-R) Expression in Prostate and Pancreatic Cancer Using Radiolabeled GRP Agonist Peptide Vectors. Proc. Am. Assoc. Cancer Res. 4, 529.
6. 105Rh labeled bombesin analogues: Enhancement of GRP receptor binding affinity utilizing aliphatic carbon chain linkers. J. Labelled Compd. Radiopharm. 40, 490-493.
7. Safavy, A., Khazaeli, M. B., Qin, H., and Buchsbaum, D. J. (1997) Synthesis of Bombesin Analogues for Radiolabeling with Rhenium-188. Cancer Suppl. 80, 2354-2359.
8. Baidoo, K. E., Lin, K.-S., Zhan, Y., Finley, P., Scheffel, U., and Wagner Jr., H. N. (1998) Design, Synthesis, and Initial Evaluation of High-Affinity Technetium Bombesin Analogues. Bioconjugate Chem. 9, 218-225.
9. Reubi, J.-C. (1995) Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging. J. Nucl. Med. 36, 1825-1835.
10. Anderson, C. J., and Welch, M. J. (1999) Radiometal-Ligand Agents (non-technetium) for diagnostic imaging. Chem. Rev. 99, 2219-2234.
11. Jurisson, S. S., and Lydon J. D. (1999) Potential technetium small molecule radiopharmaceuticals. Chem. Rev. 99, 2205-2218.
12. Deutsch, E., Libson, K., Vanderheyden, J.-L., Ketring, A. R., and Maxon, H. R. (1986) The chemistry of rhenium and technetium as related to use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13, 465-477.
13. Knapp, F. F., Jr., Mirzadeh, S., Beets, A. L., Sharkey, R., Griffiths, G., and Juweid, M. (1995) Curie-scale tungsten-188/rhenium generators for routine clinical applications, in Technetium and Rhenium in Chemistry and Nuclear Medicine (M. Nicolini, G. Bandoli and U. Mazzi, Eds.) Vol. 4, Editoriali, Padova, Italy, pp 319-324.
14. 188Re-RC-160, a somatostatin analogue. Tumor Targeting 2, 49-59.
15. Hosono, M., Hosono, M. N., Haberberger, T., Zamora, P. O., Gulhke, S., and Bender, H. (1996) Targeting of small-cell lung cancer by octreotide labeled with I-125, In-111, and Re-188 in a mouse model. Jpn. J. Cancer Res. 87, 995-1000.
16. 188Re-labeled linear alpha-melanocyte stimulating hormone analogues for specific melanoma targeting. Nucl. Med. Biol. 26, 687-693.
17. 188Re-RC-160, a directly radiolabeled somatostatin analogues. Int. J. Cancer 65, 1-8.
18. 3 as prosthetic groups for labeling amines and peptides: Approaches with pre-and postconjugate labeling. Nucl. Med. Biol. 25, 621-631.
19. 188Re Labeled Bifunctional Chelate Derived from Novel Water-Soluble Phosphines. J. Labelled Compd. Radiopharm. 42, Suppl. 1, S237-S239.
20. Eckelman, W. C., and Gibson, R. E. (1993) in Nuclear Iimaging in Drug Discovery, Development, and Approval (H. D. Burns, R. E. Gibson, R. Dannals, and P. Siegl (Eds.), Birkhauser, Boston.
21. Higley, B., Smith, F. W., Smith, T., Gemmell, H. G., Das Gupta, P., Gvozdanovic, D. V., Graham, D., Hinge, D., Davidson, J., and Lahiri, A. (1993) Technetium-99m-1,2-bis-[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J. Nucl. Med. 34, 30-38.
22. Deutsch, E., Vanderheyden, J. L., Gerundini, P., Libson, K., Hirth, W., Colombo, F., Zecca, L., Savi, A., and Fazio, F. (1987) Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humans. J. Nucl. Med. 1870-1880.
23. Deutsch, E. (1993) Aspects of the chemistry of technetium phosphine complexes. Radiochim. Acta 63, 195-197.
24. Marmion, M., DeRosch, M., Bushman, M., Wolfangel, R., Webb, E., Deutsch, K., and Deutsch, E. (1995) in Technetium and Rhenium in Chemistry and Nuclear Medicine - 4 (M. Nicolini, B. Bandoli, U. Mazzi, Eds.); Servizi Grafici Editoriali, Padova, p 253.
25. + using X-ray diffraction, EXAFS, and Tc-99 NMR. Inorg. Chem. 23, 3184-3191.
26. Deutsch, E., Glavan, K. A., Sodd, V. J., Nishiyama, H., Ferguson, D. L., and Lukes, S. J. (1981) Cationic Tc-99m complexes as potential myocardial imaging agents. J. Nucl. Med. 22, 897-907.
27. 3+ complexes containing ether analogues of DMPE. Nucl. Med. Biol. 26, 563-571.
28. Deutsch, E., Bushong, W., Glavan, K. A., Elder, R. C., Sodd, V. J., Scholz, K. L., Fortman, D. L., and Lukes, S. J. (1981) Heart imaging with cationic complexes of technetium. Science 214, 85-86.
29. 99mTc-complexes. Nucl. Med. Biol. 24, 685-691.
30. 99mTc complex with tris(hydroxymethyl)phosphine (THP). Nucl. Med. Biol. 23, 617-622.
31. + core. Nucl. Med. Biol. 26, 711-716.
32. Katti, K. V., Gali, H., Berning, D. E., and Smith, C. J. (1999) Design and development of functionalized water-soluble phosphines: Catalytic and biomedical implications. Acc. Chem. Res. 32, 9-17.
33. Gali, H., Karra, S. R., Reddy, S. V., and Katti, K. V. (1999) Design and development of the first peptide-chelating bisphosphine conjugate via a novel carboxylate functionalized phosphorus(III) hydride. Angew. Chem., Int., Ed. 38, 2020-2023.
34. 99mTc Labeling and in vivo studies of a bombesin analogue with a novel water-soluble bifunctional chelating agent. Bioconjugate Chem. 10, 254-260.
35. 99mTc Complex. Radiochim. Acta 83, 211-215.
36. Maier, L. (1972) In Organic Phosphorus Compounds (G. M. Kosolapoff, and L. Maier, Eds.) Vol. 1, John Wiley & Sons, Inc., New York, Chapter 1, pp 1-288.
37. Fritzberg, A. R., Gustavson, L. M., Hylarides, M. D., and Reno, J. M. (1994) In Chemical and Structural Approaches to Rational Drug Design, CRC Press, Boca Raton, FL.
38. Goodwin, D. A., Meares, C. F., and Osen, M. (1998) Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. J. Nucl. Med. 39, 1813-1818.
39. Behr, T. M., and Goldenberg, D. M. (1996) Improved prospects for cancer therapy with radiolabeled antibody fragments and peptides. J. Nucl. Med. 37, 834-836.
40. Colcher, D, Pavlinkova, G, Beresford, G, Booth, B. J., Choudhury, A., and Batra, S. K. (1998) Pharmacokinetics and biodstribution of genetically engineered antibodies. Q. J. Nucl. Med. 42, 225-241.
41. + type ions. Inorg. Chem. 4, 797-803.
42. Mahmoud, S., Stanley, J., Taylor, J., Bogden, A., Moreau, J. P., Coy, D., Avis, I., Cuttitta, F., Mulshine, J. L. and Moody, T. W. (1991) [Psi 13, 14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res. 51, 1798-1802.
43. Frank, A. W., Daigle, D. J., and Vail, S. L. (1982) Chemistry of Hydroxymethyl Phosphorus Compounds. III. Phosphines, Phosphine Oxides and Phosphonium Hydroxides. Text. Res. J. 52, 738-750.
44. Frank, A. W., Daigle, D. J., and Vail, S. L. (1982) Chemistry of Hydroxymethyl Phosphorus Compounds. II. Phosphonium Salts. Text. Res. J. 52, 678-693.
45. 99mTc] chelator-peptide conjugates. Bioconjugate Chem. 7, 196-202.
46. 2OH). J. Chem. Soc., Dalton Trans. 2021-2028.
47. 3OH. Inorg. Chem. 31, 3026-3033.
48. Klotzer, D., Mading, P., and Munze, R. Z. (1984) Darstellung, Complex Bildung und Charakterisierung von 1,2-Bis-[Bis(Hydroxymethyl) Phisphino]-Ethan. Z. Chem. 24, 224.
49. 2]Cl. Inorg. Chem. 35, 1753-1757.
50. 2Cl. Inorg. Chem. 36, 3928-3935.
51. Radulovic, S., Miller, G., and Schally, A. V. (1991) Inhibition of growth of HT-29 human colon cancer xenografs in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res. 51, 6006-6009.
52. Jensen, R. T., Jones, S. W., Folkers, K., and Gardner, J. D. (1984) A synthetic peptide that is a bombesin receptor antagonist. Nature 309, 61-63.
53. Janáky, T., Juhász, A., Rékási, Z., Serfözö, P., Pinski, J., Bokser, L., Srkalovic, G., Milovanovic, S., Redding, T. W., Halmos, G., Nagy, A., and Schally, A. V. (1992) Analogues of Luteinizing Hormone-Releasing Hormone Containing Cytotoxic Groups. Proc. Natl. Acad. Sci., USA 89, 972-976.
54. Pinski, J., Schally, A. V., Yano, T., Szepeshazi, K., Halmos, G., Groot, K., Schally, A. M. C., Randulovic, S., and Nagy, A. (1993) Inhibition of Growth of Experimental Prostate Cancer in Rats by LH-RH Analogues Linked to Cytotoxic Radicals. The Prostate 23, 165-178.